Abstract
The BH3-mimetic drug Venetoclax, a specific inhibitor of anti-apoptotic BCL-2, has had clinical success for the treatment of chronic lymphocytic leuka......
小提示：本篇文献需要登录阅读全文，点击跳转登录
Full Text Link
